top of page

.png)
News
Catch up on the latest news and innovation coming from Newcastle Helix


BUILDING BLOCKS Work Experience Week 2026: Bringing Future Talent and Business Together
The BUILDING BLOCKS programme continues to grow at the Innovation District of Newcastle Helix. Following the success of last year’s ground-breaking pilot, we were delighted to host a fresh cohort of enthusiastic businesses and students for our Work Experience Week 2026. In the last week of their school year, 24 Year 10 students from across Tyneside were welcomed to Newcastle Helix for a STEM-inspired experience, with a difference. Taking the form of a structured work placemen


Newcastle Helix become testbed for next-generation building technology
The Key, The Spark, The Biosphere and The Catalyst at Newcastle Helix Three of Newcastle Helix's landmark buildings are helping to shape the future of smart building management as part of a major European research and development project. The Core, The Spark and the Urban Sciences Building are now entering the testing phase of Project WILSON, a Horizon Europe EU-funded initiative bringing together businesses, universities and research organisations from across Europe to devel


Who's at Helix? | Esther Gillespie, CEO & Co-founder, Jumping Rivers
Data with Real-World Impact For Esther Gillespie, CEO & Co-founder at Jumping Rivers, the most exciting projects are those that create meaningful impact, whether that's improving business processes, increasing efficiencies or delivering health and environmental benefits. One example is the team's work with the water industry, helping organisations make sense of vast amounts of time-series data collected from multiple sources across regions and across the country. The challeng


Iksuda Therapeutics reaches major milestone in cancer treatment development
Iksuda Therapeutics, a Newcastle Helix-based biotechnology company has reached a key step in the journey from laboratory research to patient care. Iksuda Therapeutics has received clearance from the US Food and Drug Administration (FDA) to begin human clinical trials of IKS04, a new cancer treatment being developed for gastrointestinal cancers, including colorectal, gastric and pancreatic cancers. The clearance follows approval of the company's Investigational New Drug (IND)


Helix Fest Brings the Community Together
Newcastle Helix came to life as occupiers, visitors and local businesses gathered for Helix Fest – a celebration of community, collaboration and the people who make the site what it is. The event transformed the green space at the heart of Helix into a welcoming destination where people could take a break from their day, connect with others and enjoy the site in a different way. With music creating a lively atmosphere, visitors made the most of the outdoor space from table te


Leadership Spotlight: Russell Sloan on Talent, AI and the Future of Technology
Newcastle Helix is home to organisations shaping the future of industries across the UK, and we recently caught up with Russell Sloan, newly appointed CEO at Scott Logic, to hear about his vision for the business, the opportunities ahead and the trends shaping the technology sector. Having spent more than 25 years at Kainos, Russell brings extensive experience in scaling organisations, delivering large-scale digital transformation programmes and building high-performing teams
bottom of page